Talaulikar, DiptiChoudhury, AyeshaShadbolt, BruceBrown, Michael2015-12-101042-8194http://hdl.handle.net/1885/38564Lymphocytopenia has been reported to confer adverse outcomes in a number of hematological malignancies. Recently, it has been reported to be associated with poor outcome in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to determine theKeywords: anthracycline; rituximab; adult; aged; article; B cell lymphoma; cancer chemotherapy; cancer palliative therapy; cancer staging; cancer survival; clinical assessment tool; correlational study; diffuse large b cell lymphoma; drug efficacy; female; human; i Diffuse large B cell lymphoma; International prognostic index; Lymphocytopenia; Non-Hodgkin lymphoma; Survival200810.1080/104281908019590262015-12-09